This compound is a benzimidazole derivative featuring a difluorinated chromane ether side chain. It is primarily utilized as a research reagent in pharmaceutical development, with its structure suggesting potential for studying receptor interactions or biochemical pathways.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 2351939-46-1
7-[(5,7-Difluorochroman-4-yl)oxy]-2-methyl-1H-benzo[d]imidazole-5-carboxylic Acid
Pharmaceutical intermediate
Tegoprazan
potassium-competitive acid blocker
(4R)-Tegoprazan
active pharmaceutical ingredient
Loratadine N-Oxide
pharmaceutical research compound
4-(4-Cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxamide
pharmaceutical research compound
1-oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride
pharmaceutical research compound
Benzoic acid, 4-(2-(octyloxy)benzamido)-, 2-(diethylamino)ethyl ester hydrochloride
pharmaceutical research compound
N-isopropyl-2-nitrobenzenesulfonamide
research compound
7-[(5,7-difluoro-3,4-dihydro-2H-chromen-4-yl)oxy]-N,2-dimethyl-3H-benzimidazole-5-carboxamide
XSFQYWLWWMLNHM-UHFFFAOYSA-N
CC1=NC2=C(N1)C=C(C=C2OC3CCOC4=C3C(=CC(=C4)F)F)C(=O)NC